James Shin

Stock Analyst at Deutsche Bank

(0)
# 4675
Out of 5,368 analysts
22
Total ratings
33.33%
Success rate
-15.60%
Average return
14 Stocks
Name Action PT Current % Upside Ratings Updated
IMTX Immatics
Initiates Coverage On: Buy
10
6.14 62.87% 1 May 28, 2025
GILD Gilead Sciences
Upgrades: Buy
80 120
109.96 9.13% 2 Feb 18, 2025
MRK Merck & Co
Downgrades: Hold
128 105
81.72 28.49% 2 Feb 18, 2025
LLY Eli Lilly
Maintains: Buy
1025 1015
819.67 23.83% 4 Nov 4, 2024
AMGN Amgen
Reiterates: Hold
310 305
295.15 3.34% 2 Aug 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
55 60
67.74 -11.43% 2 Aug 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
53 45
49.73 -9.51% 2 Jul 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
60
36.83 62.91% 1 May 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Hold
150
190.93 -21.44% 1 Nov 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Hold
800
529.27 51.15% 1 Nov 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
25
n/a n/a 1 Nov 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
10
2.12 371.7% 1 Nov 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
12
0.8 1400% 1 Nov 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
80 70
n/a n/a 1 Dec 12, 2022